NCT06989892 Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Control Trial
| NCT ID | NCT06989892 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Navamindradhiraj University |
| Condition | The Efficacy and Safety for Super High-flux Dialyzer in Case of Sepsis in ESKD |
| Study Type | INTERVENTIONAL |
| Enrollment | 202 participants |
| Start Date | 2024-07-25 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 202 participants in total. It began in 2024-07-25 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Comparing the efficacy of superhigh-flux dialyzer with high-flux dialyzer in ESKD patient who have sepsis to improve mortality and sepsis outcome, an open label randomized control trial.
Eligibility Criteria
Inclusion Criteria: * ESKD patients who have sepsis condition with high interleukin-6 (IL-6 \> 50 pg/ml) Exclusion Criteria: * Patients who needed dialysis with continuous kidney replacement therapy, vulnerable patient, include pregnant woman, patient who expected to pass away within the 24 hours. * Patients who have the history of allergic dialyzer reaction to dialyzer which used in this trial.
Contact & Investigator
Punnawit Laungchuaychok, MD
PRINCIPAL INVESTIGATOR
Navamindradhiraj University
Frequently Asked Questions
Who can join the NCT06989892 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying The Efficacy and Safety for Super High-flux Dialyzer in Case of Sepsis in ESKD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06989892 currently recruiting?
Yes, NCT06989892 is actively recruiting participants. Contact the research team at punnawit@nmu.ac.th for enrollment information.
Where is the NCT06989892 trial being conducted?
This trial is being conducted at Dusit, Thailand.
Who is sponsoring the NCT06989892 clinical trial?
NCT06989892 is sponsored by Navamindradhiraj University. The principal investigator is Punnawit Laungchuaychok, MD at Navamindradhiraj University. The trial plans to enroll 202 participants.